Jc. Roegel et al., COMPARATIVE EFFECTS OF IDAZOXAN, PRAZOSIN, AND YOHIMBINE ON CORONARY LIGATION-INDUCED ARRHYTHMIAS IN SPONTANEOUSLY HYPERTENSIVE RATS, Journal of cardiovascular pharmacology, 27(2), 1996, pp. 226-234
We investigated whether certain drugs with alpha-adrenergic antagonist
activity display anti-arrhythmic effects in hypertensive animals subj
ected to acute coronary artery ligation. The left anterior descending
coronary artery (LAD) was ligated in open-chest pentobarbital-anesthet
ized spontaneously hypertensive rats (SHR); arrhythmias were subsequen
tly recorded for 30 min. Drugs were administered intravenously, (i.v.)
5 min before ligation. The effects of yohimbine and idazoxan were com
pared with those of prazosin. Prazosin (100 mu g/kg) increased the occ
urrence of ventricular tachycardia (VT). In contrast, yohimbine 1.6 mg
/kg decreased both the occurrence and the duration of VT and the occur
rence and the duration of ventricular fibrillation, (VF). The results
obtained with idazoxan 1 mg/kg were similar to those with yohimbine. T
he ECG alterations induced by coronary artery ligation in rats treated
with yohimbine and idazoxan were more pronounced than in controls and
in rats treated with prazosin, suggesting that the antiarrhythmic eff
ects observed were not mediated by antiischemic activity. The protecti
ve effects against ligation-induced arrhythmias were preceded by a hyp
otensive effect and a decrease in the rate-pressure product in yohimbi
ne-treated but not in idazoxan-treated animals. In rats treated with p
razosin, more arrhythmic events were observed, although hemodynamics w
ere similar to those in rats treated with yohimbine. Our results sugge
st that the yohimbine-induced antiarrhythmic action is not due to an a
lteration of conduction or repolarization rates. In this model, yohimb
ine and idazoxan appear to protect against ligation-induced arrhythmia
s. These data suggest that drugs with oi-adrenergic properties might i
nfluence the nervous drive to the heart in SHR with cardiac ischemia.
However, further investigations are needed to ascertain whether the ol
-adrenoceptor blockade participates in this effect.